A citation-based method for searching scientific literature

Margaret T Behme, John Dupré, Thomas J McDonald. BMC Endocr Disord 2003
Times Cited: 53







List of shared articles



Times cited



Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins. Reversal by Exendin-4 treatment.
Matthew R King, Nicholas J Anderson, Mihaela Deciu, Lucie S Guernsey, Morgan Cundiff, Shohreh Hajizadeh, Corinne G Jolivalt. J Neurosci Res 2020
4


Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Nicole A Sherry, Wei Chen, Jake A Kushner, Mariela Glandt, Qizhi Tang, Sue Tsai, Pere Santamaria, Jeffrey A Bluestone, Anne-Marie B Brillantes, Kevan C Herold. Endocrinology 2007
138

New potential adjuncts to treatment of children with type 1 diabetes mellitus.
Vandana S Raman, Rubina A Heptulla. Pediatr Res 2009
13

Glucagon-like peptide 1(GLP-1) in biology and pathology.
Juris J Meier, Michael A Nauck. Diabetes Metab Res Rev 2005
196

Is exenatide a useful addition to diabetes therapy?
Nasser E Mikhail. Endocr Pract 2006
4




GLP-1: physiological effects and potential therapeutic applications.
Kasper Aaboe, Thure Krarup, Sten Madsbad, Jens Juul Holst. Diabetes Obes Metab 2008
57